These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7791697)

  • 21. Current management recommendations for rheumatoid arthritis.
    Paget SA; Fafalak RG
    Contemp Intern Med; 1994 Sep; 6(9):35-43. PubMed ID: 10150307
    [No Abstract]   [Full Text] [Related]  

  • 22. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
    Rooney T; Murphy E; Benito M; Roux-Lombard P; FitzGerald O; Dayer JM; Bresnihan B
    Ann Rheum Dis; 2004 Nov; 63(11):1393-8. PubMed ID: 15479888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 24. [New approaches to the therapy of rheumatoid arthritis].
    Balabanova RM; Egorova ON
    Ter Arkh; 1996; 68(12):78-82. PubMed ID: 9054051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.
    Verburg RJ; Flierman R; Sont JK; Ponchel F; van Dreunen L; Levarht EW; Welling MM; Toes RE; Isaacs JD; van Laar JM
    Ann Rheum Dis; 2005 Oct; 64(10):1397-405. PubMed ID: 15829573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Australian Rheumatology Association Database (ARAD).
    Williams MP; Buchbinder R; March L; Lassere M
    Semin Arthritis Rheum; 2011 Feb; 40(4):e2-3. PubMed ID: 21168188
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.
    Silverman GJ
    Arthritis Rheum; 2006 Aug; 54(8):2356-67. PubMed ID: 16868991
    [No Abstract]   [Full Text] [Related]  

  • 28. Rheumatoid arthritis initial therapy: unanswered questions.
    O'Dell J
    J Rheumatol Suppl; 2005 Jan; 72():14-6. PubMed ID: 15660457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.
    Cañete JD; Celis R; Moll C; Izquierdo E; Marsal S; Sanmartí R; Palacín A; Lora D; de la Cruz J; Pablos JL
    Ann Rheum Dis; 2009 May; 68(5):751-6. PubMed ID: 18495732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The humoral response in rheumatoid arthritis and the effect of B-cell depleting therapy].
    Thurlings RM; Vos K; Gerlag DM; Tak PP
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1657-61. PubMed ID: 16922350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modern treatment of rheumatoid arthritis].
    Surányi P
    Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment and management of early RA: A primary care primer.
    Costenbader KH; Kountz DS
    J Fam Pract; 2007 Jul; 56(7 Suppl):S1-7; quiz S8. PubMed ID: 17605944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatoid arthritis drug update.
    Johns Hopkins Med Lett Health After 50; 2008 May; 20(3):4-5, 7. PubMed ID: 18652033
    [No Abstract]   [Full Text] [Related]  

  • 34. Issues in rheumatology and autoimmunity. Preface.
    Sherer Y
    Isr Med Assoc J; 2008 Feb; 10(2):138. PubMed ID: 18432028
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of prognostic markets to guide biologic therapies for rheumatoid arthritis.
    D'Arcy CA; Willkens RF
    J Rheumatol; 2002 Dec; 29(12):2662; author reply 2662-3. PubMed ID: 12465172
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis.
    Kirwan J; Power L
    Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
    VanderBorght A; Geusens P; Raus J; Stinissen P
    Semin Arthritis Rheum; 2001 Dec; 31(3):160-75. PubMed ID: 11740797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The future of RA treatment].
    Matsubara T
    Ryumachi; 1997 Oct; 37(5):679-80. PubMed ID: 9396369
    [No Abstract]   [Full Text] [Related]  

  • 39. [New therapeutic possibilities. Future aspects].
    Rubbert A; Burmester GR
    Internist (Berl); 1993 Sep; 34(9):841-51. PubMed ID: 8407201
    [No Abstract]   [Full Text] [Related]  

  • 40. Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
    VanderBorght A; De Keyser F; Geusens P; De Backer M; Malaise M; Baeten D; Van den Bosch F; Veys EM; Raus J; Stinissen P
    J Rheumatol; 2002 Mar; 29(3):416-26. PubMed ID: 11908552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.